Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Hydroxytyrosol Dietary Supplement and Prevention of Age-Related Diseases [NA]

View source ↗

Summary

This document reports on a completed clinical trial evaluating hydroxytyrosol as a dietary supplement for overweight and prediabetes, sponsored by the National …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxytyrosol dietary supplement (hydroxytyrosol)

Snippet

Sponsor: National Research Council, Spain | Conditions: Overweight, PreDiabetes | NA | Status: COMPLETED